Navigation Links
Phthalic symbol
Date:6/19/2009

Immobilized microbes can break down potentially harmful phthalates, according to researchers in China, writing in the International Journal of Environment and Pollution. The microbes might be used to treat industrial waste water and so prevent these materials from entering the environment.

Phthalic Acid Esters (PAEs), commonly known as phthalates, are widely used as additives in polymer manufacture as plasticizers. They do not readily degrade in the environment and so have become widely distributed in natural water, wastewater, soils, and sediment.

Concerns about their suspected ability to cause genetic mutations and cancer have led to their listing as priority pollutants by the US Environmental Protection Agency, the European Union, the China National Environmental Monitoring Centre, and other regulatory authorities.

Weizhong Wu of the College of Environmental Sciences and Engineering, at Peking University, in Beijing, and Xianlin Meng of Harbin Institute of Technology, in Nangang District, have identified and isolated a microbe that can digest one of the most common PAEs, d-n-butyl phthalate. This compound is widely used and is one of the most frequently found in diverse environmental samples including groundwater, river water, drinking water, open ocean water, soil humates, lake sediments and marine sediments, the researchers say.

They have now used acclimation and enrichment techniques to ferment adequate quantities of the active microbe, which was obtained from the activated sludge from a wastewater treatment plant. It was enriched and acclimated by incubating activated sludge. This involves cultivating the microbes in a solution containing phthalate as the only source of carbon for the microbes. Successive divisions of microbial cells quickly leads to the evolution of a strain that can quickly metabolize the phthalate and convert it into the raw materials for microbial growth and reproduction.

The researchers then tested this phthalate-digesting microbe by immobilizing cells on a new type of ceramic honeycomb support. They then measured the before and after concentration of phthalate in a simulated wastewater sample. Initial concentration was 100 milligrams per liter which fell to less than 1.0 milligram per liter within two days of treatment with the microbial honeycomb.

The team points out that the rate of degradation was two and a half times faster with immobilized microbes than with microbes floating free in the sample.


'/>"/>

Contact: Weizhong Wu
wuweizhong@pku.edu.cn
Inderscience Publishers
Source:Eurekalert

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... Minn. , Nov. 22, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... Medical LiveWire Healthcare and Life Sciences Awards ... award caps off an unprecedented year of recognition and ... trials for over 15 years. iMedNet ...
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
(Date:11/14/2016)... 14, 2016  xG Technology, Inc. ("xG" or the ... wireless communications for use in challenging operating environments, announced ... 2016. Management will hold a conference call to discuss ... Eastern Time (details below). Key Recent Accomplishments ... million binding agreement to acquire Vislink Communication Systems. The ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... the FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, ... require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/7/2016)... Diego (PRWEB) , ... December 07, 2016 , ... ... data from its phase I/II dose escalation and expansion clinical trial for its ... in Vienna, Austria. The purpose of the trial was to determine the safety, ...
Breaking Biology Technology: